[Sweet's syndrome: report of 5 cases].
Sweet's syndrome is an acute febrile neutrophilic dermatoses. Cutaneous signs are the main manifestations. The objective of this study is to deal with the epidemiological and clinical aspects of the disease and its treatment. It is a retrospective study over a period of 5 years (2000- 2004). We have included all the patients with characteristic clinical, biological and histological features. Five patients had been identified. They were all females. Their mean age was 42, 2 years. All patients had typical clinical, histological and biological features. Crohn disease was associated in one case. Sweet's syndrome responds rapidly to systemic therapy with corticosteroids and/or nonsteridal anti-inflammatory agents. Sweet's syndrome is a rare disease which occurs mainly in middle-aged women. This was found in our study. Corticosteroids are the standard therapy. Several diseases, particularly neoplasms and inflammatory diseases, can bee associated with Sweet's syndrome and condition the prognosis.
Rjeibi
I
I
Service de Dermatologie, Hôpital Charles Nicolle, Tunis, Tunisie. imenrjeibi@yahoo.fr
Zeglaoui
F
F
El Fekih
N
N
Ezzine
N
N
Fazaa
B
B
Kamoun
M R
MR
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications; D005260:Female; D006801:Humans; D007964:Leukocytosis / Q000503:physiopathology; D008875:Middle Aged; D012189:Retrospective Studies; D016463:Sweet Syndrome / Q000175:diagnosis* / Q000503:physiopathology; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal